Companies / Maxcyte, Inc. / Activity
Activity — Maxcyte, Inc.
21 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Johnston John Joseph Director | Grant | Common Stock | $0 | +30K +17.77% | 201,581 0.19% of shares | low |
| Jun 17, 2026 | Hemrajani Rekha Director | Grant | Common Stock | $0 | +30K +76.26% | 70,314 0.07% of shares | low |
| Jun 17, 2026 | Erck Stanley C Director | Grant | Common Stock | $0 | +30K +7.64% | 428,749 0.40% of shares | low |
| Jun 17, 2026 | Collins Cynthia Director | Grant | Common Stock | $0 | +30K +37.61% | 111,310 0.10% of shares | low |
| Jun 17, 2026 | Brooke William W Director | Grant | Common Stock | $0 | +30K +20.16% | 181,300 0.17% of shares | low |
| Jun 17, 2026 | Al-Wakeel Yasir B. Director | Grant | Common Stock | $0 | +30K +60.15% | 80,998 0.08% of shares | low |
| Apr 15, 2026 | Ahuja Parmeet Executive | Grant | Common Stock | $0 | +188K | 187,500 0.18% of shares | low |
| Jun 17, 2026 | Balthrop Patrick J Director | Grant | Common Stock | $0 | +30K +60.15% | 80,998 0.08% of shares | low |
| Jun 17, 2026 | Douglas Richard Director | Grant | Common Stock | $0 | +30K +13.19% | 260,998 0.24% of shares | low |
| Mar 27, 2026 | Masoud Maher CEO | Grant | Common Stock | $0 | +300K +171.43% | 475,000 0.44% of shares | low |
| Mar 17, 2026 | Swirsky Douglas J Executive | Sell | Common Stock | $8.3K | -10K -6.27% | 151,669 0.14% of shares | low |
| Jun 17, 2026 | Johnston John Joseph Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Jun 17, 2026 | Hemrajani Rekha Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Jun 17, 2026 | Erck Stanley C Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Jun 17, 2026 | Collins Cynthia Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Jun 17, 2026 | Brooke William W Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Jun 17, 2026 | Al-Wakeel Yasir B. Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Mar 30, 2026 | Ahuja Parmeet Executive | Grant | Employee Stock Option (right to buy) | — | +375K | 375,000 0.35% of shares | low |
| Jun 17, 2026 | Balthrop Patrick J Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Jun 17, 2026 | Douglas Richard Director | Grant | Stock Option (right to buy) | — | +50K | 49,579 0.05% of shares | low |
| Mar 27, 2026 | Masoud Maher CEO | Grant | Employee Stock Option (right to buy) | — | +600K | 600,000 0.56% of shares | low |